Gemfibrozil Induces Anemia, Leukopenia and Reduces Hematopoietic Stem Cells via PPAR-α in Mice
Hypercholesterolemia, also called high cholesterol, is a form of hyperlipidemia, which may be a consequence of diet, obesity or diabetes. In addition, increased levels of low-density lipoprotein (LDL) and reduced levels of high-density lipoprotein (HDL) cholesterol are associated with a higher risk...
Main Authors: | Gabriel Rufino Estrela, Adriano Cleis Arruda, Heron Fernandes Vieira Torquato, Leandro Ceotto Freitas-Lima, Mauro Sérgio Perilhão, Frederick Wasinski, Alexandre Budu, Ricardo Ambrósio Fock, Edgar Julian Paredes-Gamero, Ronaldo Carvalho Araujo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/14/5050 |
Similar Items
-
The Peroxisome Proliferator-Activated Receptor α- Agonist Gemfibrozil Promotes Defense Against <i>Mycobacterium abscessus</i> Infections
by: Yi Sak Kim, et al.
Published: (2020-03-01) -
PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2
by: Leandro Ceotto Freitas-Lima, et al.
Published: (2020-10-01) -
Ameliorative potential of gemfibrozil and silymarin on experimentally induced nephrotoxicity in rats
by: A.M. Kabel, et al.
Published: (2013-12-01) -
Leukopenia Related to Haloperidol in a Case of Chronic Untreated Schizophrenia
by: Hrishikesh B Nachane, et al.
Published: (2021-01-01) -
Effects of Fenofibrate and Gemfibrozil on Kynurenic Acid Production in Rat Kidneys In Vitro: Old Drugs, New Properties
by: Izabela Zakrocka, et al.
Published: (2023-11-01)